We are live on
!
Find out more
IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
IDXG
Delisted
IDXG was delisted on the 24th of February, 2021.
14 hedge funds and large institutions have $2.71M invested in Interpace Biosciences, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
22% less funds holding
Funds holding: 18 → 14 (-4)
27% less capital invested
Capital invested by funds: $3.72M → $2.71M (-$1.01M)
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
Holders
14
Holders Change
-4
Holders Change %
-22.22%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
4
Reduced
3
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$74.4K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$2.06K |
| 3 |
BlackRock
New York
|
+$854 |
| 4 |
LCC
Lincoln Capital Corp
East Greenwich,
Rhode Island
|
+$360 |
| 5 |
Morgan Stanley
New York
|
+$226 |
